Dose-Dense Epirubicin and Cyclophosphamide Followed by Docetaxel as Adjuvant Chemotherapy in Node-Positive Breast Cancer

Dose-Dense Epirubicin and Cyclophosphamide Followed by Docetaxel as Adjuvant Chemotherapy in Node-Positive Breast Cancer

Background. Adding taxanes to anthracycline-based adjuvant chemotherapy has shown significant improvement particularly in node-positive patients, but optimal dose and schedule remain undetermined. Objectives. This study aimed to assess the feasibility of dose-dense epirubicin and cyclophosphamide fo...

Full description

Saved in:
Bibliographic Details
Main Authors: Hamid Reza Mirzaei, Parisa Sabet Rasekh, Fatemeh Nasrollahi, Parto Sabet Rasekh, Zahra Akbari Tirabad, Hamid Reza Moein, Taban Ghaffari Pour, Parastoo Hajian
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:International Journal of Breast Cancer
Online Access:http://dx.doi.org/10.1155/2013/404396
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items